摘要:
目的:研究苏黄止咳胶囊联合硫酸特布他林对咳嗽变异性哮喘(CVA)的治疗效果.方法:选取进行CVA治疗的患者210例,随机分为对照组和观察组,对照组和观察组各105例,治疗14d后观察治疗效果,并进行疗效评价;测定治疗前后患者的肺功能指标,包括第一秒用力呼气容积(FEV1) 、用力肺活量(FVC)和最高呼气流速(PEF) ;测定治疗前后患者血清IgE及 T 淋巴细胞亚群的变化;对治疗过程中患者出现的副反应进行统计分析.结果:经过治疗,观察组治疗的总有效率(92.38%)显著高于对照组(72.38%)( P<0.05) ;治疗后,对照组与观察组的FEV1 、FVC和PEF均有了显著提升( P<0.05) ,其中观察组的变化比对照组大( P<0.05) ;与治疗前相比,对照组与观察组的IgE含量均显著降低(P<0.05) ,其中治疗后观察组的值显著低于对照组(P<0. 05) ;与治疗前相比,对照组与观察组中CD3+、CD4+和CD4+/CD8+显著增加,CD8+显著降低( P<0.05) ,与对照组相比,观察组变化更大(P<0.05) ;对照组与观察组均出现了不同程度的副反应,对照组不良反应率(35.24%)显著高于观察组(14.29%)( P<0.05).结论:苏黄止咳胶囊和硫酸特布他林联合使用可以有效的提高治疗有效率、改善肺功能、降低不良反应的发生率,这可能与二者联合治疗能够降低IgE含量,提高CD3+、CD4+的比例,降低CD8+的比例,从而减少炎性因子的释放,增强患者免疫功能有关.%Objective:The therapeutic effect of Suhuang Zhike capsule combined with terbutaline sulfate on cough variant asthma.Methods:210 patients treated with CVA in our hospital from September 2014 to August 2017 were randomly divided into control group and observation group,the treatment effect after 14 days and the curative effect were observed ;lung function parameters before and after treatment were measured,which including forced expiratory volume in 1 second (FEV1),forced vital capacity (FVC),and maximum expiratory flow rate (PEF) ;changes of serum IgE and T lymphocyte subsets before and after treatment were determined ;statistical analysis of side reactions occurring in patients during treatment were calculated.Results:After treatment,the total effective rate (92.38%) in the observation group was significantly higher than that in the control group (72.38%) (P<0. 05) ;after treatment,the FEV1,FVC and PEF in the control group and the observation group had significantly in-creased (P<0.05),and the change in the observation group was larger than that in the control group (P<0.05) ;compared with before treatment,the IgE levels in the control group and the observation group were significantly lower (P<0.05),and the value of the observation group after treatment was significantly lower than that of the control group (P<0.05) ;compared with before treatment,CD3+,CD4+,and CD4+/CD8+increased significantly in the control group and the observation group,and CD8+decreased significantly (P<0.05) ;compared with the control group,the observation group changed more (P<0.05) ;both the control group and the observation group had different degrees of side effects.The adverse reaction rate in the control group (35.24%) was significantly high-er than that in the observation group (14.29%) (P<0.05).Conclusion:The combined use of Suhuang Zhike capsule and terbutaline sulfate can effectively improve the treatment efficiency,lung function,and reduce the incidence of ad-verse reactions.This may be related to the combination of the two can reduce IgE content,increase the proportion of CD3+,CD4+,reduce the proportion of CD8+,thereby reducing the release of inflammatory factors and enhance the patient's immune function.